Published on 08/12/2025

Training/Validation/Test Splits: Leakage and Contamination Controls

The incorporation of Artificial Intelligence (AI) and Machine Learning (ML) into the pharmaceutical industry has accelerated advancements in drug discovery, clinical trials, and numerous other applications. However, ensuring the reliability and compliance of these models is crucial. In this comprehensive guide, we will explore key aspects of AI/ML model validation, focusing specifically on the segregation of training, validation, and test datasets to control leakage and contamination risks. This document will also discuss compliance with regulations such as 21 CFR Part 11 and GAMP 5, along with strategies for effective governance.

Understanding AI/ML Model Validation in a Regulatory Context

AI/ML model validation is a critical component of GxP (Good Practice) compliance in the pharmaceutical and biotech industries. The purpose of this validation is to ensure that the models used for data analysis, predictive analytics, and decision-making are fit for their intended use, adequately developed, and free from bias.

In the US, regulatory frameworks such as the FDA have been increasingly focused on how AI/ML can be integrated safely into patient care. Similarly, the European Medicines Agency (EMA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) are ensuring that AI/ML technologies meet the appropriate standards of quality and efficacy.

Key elements of AI/ML model validation include:

• Intended Use & Data Readiness: Clearly define the purpose of the model and confirm that data is well-prepared for model training and validation.
• Model Verification and Validation (V&V): Follow a structured process to verify that the model meets specified requirements and validate its performance against real-world scenarios.
• Bias and Fairness Testing: Assess models for biases that may emerge in training data to ensure fairness in predictions.
• Explainability (XAI): Establish interpretability of model decisions to comply with both ethical standards and regulatory demands.
• Drift Monitoring & Re-Validation: Implement strategies to monitor for performance drift and establish protocols for re-validation over time.

Establishing Intended Use and Ensuring Data Readiness

The first step in the model validation process is outlining the intended use of the AI/ML application. This definition must be clearly articulated, as it informs the entire validation approach, including data requirements, performance metrics, and regulatory considerations.

Data readiness refers to the preparation and curation of datasets before they are utilized for training or validation. Here are the steps to ensure data readiness:

Step 1: Identify Data Sources

Identify and catalog all potential data sources that can be utilized for the model. This may include clinical trial data, electronic health records, or patient surveys. Transparency regarding data sources is key to ensuring compliance.

Step 2: Assess Data Quality

Evaluate data quality by checking for inaccuracies, missing values, and duplicates. Techniques such as data profiling can assist in identifying potential issues. By maintaining high data quality, you minimize the risk of biases affecting model performance.

Step 3: Data Transformation and Standardization

Transform data into a suitable format for model training, which may involve normalization, standardization, and encoding categorical variables. By standardizing your inputs, you enhance model interpretability and accuracy.

Step 4: Ensure Compliance with Regulatory Guidelines

Verify that all data handling procedures align with applicable regulations, such as maintaining compliance with 21 CFR Part 11, which governs electronic records and electronic signatures, and Annex 11, which outlines rules for computerized systems in GMP processes. Follow the GAMP 5 guidelines for validating software applications to ensure that all required documentation is in place.

Model Verification and Validation Techniques

Once the data is prepared and the intended use is established, the next phase is to implement verification and validation of the AI/ML model. This involves thorough testing of both the model’s functionality and its outcomes against predetermined criteria.

Step 1: Model Verification

Verification involves checking that the model has been built correctly based on the requirements set during the intended use phase. Techniques may include:

• Unit Testing: Test each part of the model separately to ensure they function as expected.
• Integration Testing: Evaluate how various parts of the model work together in conjunction.

Step 2: Model Validation

Validation is performed to ascertain that the model meets the performance standards required for its intended use. Here are some strategies for proper validation:

• Cross-Validation: Utilize techniques such as k-fold cross-validation to evaluate the model’s ability to generalize to unseen data.
• Performance Metrics: Define success metrics such as accuracy, precision, recall, and F1 score to quantitatively measure model performance.
• Stakeholder Review: Involve regulatory and scientific stakeholders in the validation process for comprehensive insights and feedback.

Bias and Fairness Testing

Bias in AI/ML models can lead to inaccurate predictions and unjust outcomes, particularly in areas such as healthcare. Therefore, rigorous bias and fairness testing is crucial to ensure that the models perform equitably across different population segments. The following steps outline an approach to testing for bias:

Step 1: Define Fairness Criteria

Establish clear fairness metrics based on ethical considerations and stakeholder expectations. This may involve measures such as demographic parity or equality of opportunity.

Step 2: Analyze Training Data

Evaluate the training data for representativeness to ensure diverse population coverage. Bias can emerge if data predominantly represents one demographic group. Implement techniques such as re-sampling or augmentation to address imbalances in the dataset.

Step 3: Conduct Fairness Assessments

Assess the model’s predictions for fairness and equity interaction. This involves analyzing outcomes across various demographics (e.g., age, race, gender) to identify any discrepancies in predictive accuracy. Employ established statistical techniques to quantify fairness metrics.

Establishing Explainability in Models (XAI)

Explainable AI (XAI) refers to methods and techniques in AI that provide transparency and clarity about model functionality and decision-making processes. Explainability is essential not only for compliance but also for building trust among users.

Step 1: Implement Interpretable Models

Whenever possible, choose algorithms that yield inherently interpretable results, such as linear regression or decision trees. For more complex models, alternative methods such as SHAP (SHapley Additive exPlanations) may be utilized to explain predictions.

Step 2: Documentation of Explainability

Thoroughly document how functionalities were implemented to achieve explainability. Compliance documentation should outline the approach taken for model development, any model assumptions made, and how explainability was assessed and validated.

Step 3: Engage Stakeholders on Explainability

Regularly communicate with stakeholders, including regulatory agents and end-users, regarding model explainability. Workshops and seminars can be beneficial for clarifying model workings and demonstrating transparency.

Implementing Drift Monitoring and Re-Validation

Data drift occurs when the data distribution changes over time, which can lead to deteriorating model performance. Implementing drift monitoring alongside re-validation procedures is critical to ensure ongoing model reliability.

Step 1: Establish Drift Detection Mechanisms

Monitor model predictions against real-world outcomes to detect any drift in data distributions. Techniques such as statistical tests (e.g., Kolmogorov-Smirnov) can help in identifying changes in distributions.

Step 2: Plan for Re-Validation

Develop a re-validation protocol that outlines when and how models will be evaluated after drift is detected. This should include procedures for data collection, performance evaluation metrics, and documentation of any changes made to the model.

Step 3: Documentation and Audit Trails

Maintain clear documentation and audit trails regarding model evolution and performance monitoring. This will ensure transparency and compliance, facilitate audits, and support opportunities for continuous improvement.

Establishing AI Governance and Security

With the integration of AI/ML in pharmaceutical operations, robust governance and security measures must be adopted to align with industry standards and regulatory expectations.

Step 1: AI Governance Framework

Develop a comprehensive governance framework that outlines roles and responsibilities, resources, and methods for oversight. Include policies for model documentation, ethical use, and bias mitigation within the governance structure.

Step 2: Security Protocols

Implement security measures that protect model integrity and data privacy, especially in accordance with regulations such as GDPR in the EU and 21 CFR Part 11 in the US. Security protocols should encompass access controls, data encryption, and regular security assessments.

Step 3: Continuous Education and Training

Foster a culture of continuous learning through training programs focused on AI governance, ethical use of AI, and regulatory compliance. Engaging staff will enhance overall understanding and adherence to intended practices.

Conclusion

As the pharmaceutical industry increasingly shifts towards AI/ML technologies, ensuring that robust processes for validation, bias testing, explainability, and governance are in place is critical for compliance and ethical responsibility. Following the outlined steps can help pharma professionals effectively navigate the complexities of AI/ML model validation while adhering to regulatory expectations from bodies like the FDA, EMA, and MHRA.

Incorporating these best practices in AI/ML model validation not only mitigates risks related to leakage and contamination but also enhances the reliability of AI systems, ultimately supporting better patient outcomes.